Journal
CLINICAL & TRANSLATIONAL ONCOLOGY
Volume 22, Issue 5, Pages 647-662Publisher
SPRINGER INTERNATIONAL PUBLISHING AG
DOI: 10.1007/s12094-019-02182-z
Keywords
Colorectal cancer; Liver metastases; Surgery; Chemotherapy; Locoregional therapies; Consensus
Categories
Funding
- Spanish Society of Medical Oncology
- Spanish Association of Surgeons
- Spanish Society of Radiation Oncology
- Spanish Society of Vascular and Interventional Radiology
- Spanish Society of Nuclear Medicine and Molecular Imaging
Ask authors/readers for more resources
Colorectal cancer (CRC) has the second-highest tumor incidence and is a leading cause of death by cancer. Nearly 20% of patients with CRC will have metastases at the time of diagnosis, and more than 50% of patients with CRC develop metastatic disease during the course of their disease. A group of experts from the Spanish Society of Medical Oncology, the Spanish Association of Surgeons, the Spanish Society of Radiation Oncology, the Spanish Society of Vascular and Interventional Radiology, and the Spanish Society of Nuclear Medicine and Molecular Imaging met to discuss and provide a multidisciplinary consensus on the management of liver metastases in patients with CRC. The group defined the different scenarios in which the disease can present: fit or unfit patients with resectable liver metastases, patients with potential resectable liver metastases, and patients with unresectable liver metastases. Within each scenario, the different strategies and therapeutic approaches are discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available